SEBI imposes Rs. 22 cr fine on Aurobindo Pharma for insider trading

SEBI imposes fine on Aurobindo Pharma

Points to Remember:

  • Markets regulator SEBI has imposed over Rs. 22 crore penalty on Aurobindo Pharma and its promoters for violation of provisions of insider trading.
  • The insider trading was in relation to a licencing deal it had entered with Pfizer in 2009.
  • SEBI said it carried out investigations in Aurobindo Pharma between 2008-09 following a sudden increase in the share price.

About SEBI :

  • The Securities and Exchange Board of India is the regulator for the securities market in India.
  • It was established in 1988 and given statutory powers on 12 April 1992 through the SEBI Act, 1992.
  • Founded: 12 April 1992
  • Sector: Securities market
  • Headquarters: Mumbai
  • Type: Statutory corporation
  • Chairperson: Ajay Tyagi
Important Possible questions based on above News:
  1. Market regulator _ has imposed over Rs. 22 crore penalty on Aurobindo Pharma. SEBI
  2. Who is the chairman of SEBi at present? Ajay Tyagi

 

NO COMMENTS:

Your email address will not be published. Required fields are marked *